Eli Lilly-Loxo Oncology deal gets US antitrust clearance
MLex Summary: Eli Lilly's plan to buy Loxo Oncology has received clearance from US antitrust authorities, according to a Loxo Oncology securities filing. The waiting period on the deal expired Jan....To view the full article, register now.
Already a subscriber? Click here to view full article